Latest Voluntary Suspension News

Scorpion Minerals Limited has requested a voluntary suspension of its ASX-listed securities pending critical announcements on assay results, a tenement application, a strategic partnership, and financing developments.

OZZ Resources advances exploration with fresh gold anomalies at Maguires Reward and pursues a joint venture to unlock project potential amid ongoing ASX suspension.

ASF Group Limited has voluntarily suspended trading of its securities on the ASX pending a response to regulatory queries, signaling heightened scrutiny and market uncertainty.

Australian Oil Company Limited has voluntarily suspended trading on the ASX as it finalizes a capital raising deal, with details expected by 24 October 2025.

Arrow Minerals Limited has suspended all field activities in Guinea due to unresolved questions over exploration permit renewals, maintaining a cautious financial stance while awaiting government clarity.

Vectus Biosystems has requested an immediate suspension of its ASX-listed shares pending a significant announcement about a transaction involving a compound in its drug library.

Magnum Mining and Exploration Limited has voluntarily suspended trading of its shares pending a significant capital raise announcement, signaling a pivotal moment for the company.

Equity Story Group Ltd has voluntarily suspended trading of its shares pending a forthcoming announcement about a capital raise, signaling a significant funding event.

Theta Gold Mines has requested a voluntary suspension of its shares on the ASX pending a significant announcement related to funding and its TGME Gold Mine Project.

Gold Mountain Limited has increased its capital raise to $2 million by issuing nearly 30 million shares at a slightly higher price, lifting its voluntary trading suspension and reinforcing its exploration ambitions.

Gold Mountain Limited has voluntarily suspended trading on the ASX pending an announcement that will update the issue price of a recent capital raising placement.

Invex Therapeutics has voluntarily suspended trading on the ASX pending a significant acquisition announcement and responses to a price query. The suspension is expected to last until the announcement or early next week.